Cutting-Edge CAR T-Cell Treatment Has The Potential To Reverse Metabolic Dysfunction Brought On By Ageing.
Source-News-Medical The efficacy of a senolytic therapy based on chimeric antigen receptor (CAR) T-cells is assessed in a new study published in Nature Ageing. Senolytic CAR T-cells are used in this therapy to specifically target urokinase plasminogen activator receptor (uPAR)-positive cells, which proliferate with age. Context Stress causes an irreversible cell cycle arrest known as cellular senescence. Senescence-associated secretory phenotype (SASP) refers to the production of pro-inflammatory cytokines and matrix remodelling enzymes under stressful situations. SASP helps draw in immune cells that support tissue repair and senescent cell elimination in young people with physiological circumstances like wound healing and tumour suppression. Senescent cells proliferate in older people because their immune systems are less effective and their tissue damage is greater. Until yet, the majority of senoylatic therapy have consisted of small-molecule medications that are poorly...